Newsroom

Sorted by: Latest

-

Incyte gibt positive CHMP-Stellungnahme zu Zynyz® (Retifanlimab) für die Erstlinienbehandlung von fortgeschrittenem Plattenepithelkarzinom des Analkanals (Squamous Cell Carcinoma of the Anal Canal, SCAC) bekannt

MORGES, Schweiz--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) hat heute bekannt gegeben, dass das Committee for Medicinal Products for Human Use (CHMP) der Europäischen Arzneimittelagentur (European Medicines Agency, EMA) eine positive Stellungnahme abgegeben hat, in der die Zulassung von Zynyz® (Retifanlimab) in Kombination mit Carboplatin und Paclitaxel (platinbasierte Chemotherapie) zur Erstlinienbehandlung von erwachsenen Patienten mit metastasiertem oder inoperablem lokal rezidivierendem Platten...
-

Riassunto: Incyte annuncia il parere favorevole del CHMP per Zynyz® (retifanlimab) per il trattamento di prima linea del carcinoma anale squamocellulare (SCAC) in fase avanzata

MORGES, Svizzera--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che il Comitato per i medicinali per uso umano (CHMP) dell'Agenzia europea per i medicinali (EMA) ha rilasciato il parere favorevole che ha raccomandato l'approvazione di Zynyz® (retifanlimab) in combinazione con carboplatino e paclitaxel (chemioterapia a base di platino) per il trattamento di prima linea di pazienti adulti con carcinoma anale squamocellulare (SCAC) localmente ricorrente metastatico o inoperabile. Il tes...
-

Ocean Bank Records Double-Digit Growth

MIAMI--(BUSINESS WIRE)--Ocean Bank today announced double-digit growth in assets, deposits and stockholder’s equity for 2025, compared to year-end 2024. Total assets reached $7.44 billion, an increase of 11 percent during the year, while deposits grew 12 percent to $6.27 billion. “This growth reflects Ocean Bank’s constant dedication to meeting our customers’ needs,” said Agostinho Alfonso Macedo, President, Chairman and CEO of Ocean Bank. “Strong customer relationships drove increases in loans...
-

Incyte annonce un avis favorable du CHMP concernant Zynyz® (retifanlimab) pour le traitement de première ligne du carcinome épidermoïde du canal anal (SCAC)

MORGES, Suisse--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd'hui que le Comité des médicaments à usage humain (CHMP) de l'Agence européenne des médicaments (EMA) a émis un avis positif recommandant l'approbation de Zynyz® (retifanlimab) en association avec le carboplatine et le paclitaxel (chimiothérapie à base de platine) pour le traitement de première ligne des patients adultes atteints d'un carcinome épidermoïde métastatique ou localement récidivant inopérable du canal anal (SCA...
-

Mediawan s’apprête à acquérir The North Road Company pour créer une nouvelle plateforme indépendante de contenu d’envergure mondiale

PARIS et LOS ANGELES--(BUSINESS WIRE)--Mediawan, le studio indépendant européen de premier plan dirigé par Pierre-Antoine Capton, et cofondé par ce dernier, Xavier Niel et Matthieu Pigasse, a annoncé aujourd’hui la signature d’un accord en vue d’acquérir The North Road Company (« North Road »), le studio indépendant américain majeur fondé par Peter Chernin. Cette union donne naissance à l’un des plus grands studios indépendants au monde, avec des pôles créatifs majeurs sur les cinq continents e...
-

Resumen: Incyte anuncia una opinión positiva de Zynyz® (retifanlimab) del CMUH para tratamiento de primera línea del carcinoma de células escamosas del canal anal avanzado

MORGES (Suiza)--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) anunció hoy que el Comité de Medicamentos de Uso Humano (CMUH) de la Agencia Europea de Medicamentos (EMA) emitió una opinión positiva en la que recomienda la aprobación de Zynyz® (retifanlimab) en combinación con carboplatino y paclitaxel (quimioterapia basada en platino) para el tratamiento de primera línea de pacientes adultos con carcinoma de células escamosas del canal anal recurrente metastásico o inoperable localmente. El comunicado...
-

Willdan Announces Date of Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call

ANAHEIM, Calif.--(BUSINESS WIRE)--Willdan Group, Inc. (“Willdan”) (Nasdaq: WLDN), today announced that it will release its financial results for the fourth quarter 2025 after the close of the stock market on Thursday, February 26, 2026. Following the release, Willdan will host its investor conference call at 5:30 p.m. ET / 2:30 p.m. PT. An online, real-time audio webcast of the quarterly investor conference call will be available on Willdan’s website at: Willdan Group Q4 2025 Investor Conferenc...
-

BTDR Deadline: Rosen Law Firm Urges Bitdeer Technologies Group (NASDAQ: BTDR) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025. Bitdeer is a bitcoin mining and high-performance computing (HPC) data-center infrastructure company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigati...
-

Resumen: Mediawan adquiere The North Road Company y crea una nueva plataforma global de contenidos independiente

PARÍS y LOS ÁNGELES--(BUSINESS WIRE)--Mediawan, el estudio europeo líder del sector, dirigido por Pierre-Antoine Capton y cofundado por Pierre-Antoine Capton, Xavier Niel y Matthieu Pigasse, anunció hoy la firma de un acuerdo para adquirir The North Road Company («North Road»), el estudio estadounidense de referencia fundado por Peter Chernin. La operación dará lugar a uno de los mayores estudios del mundo, con importantes centros creativos en los cinco continentes y presencia en todos los géne...
-

Generational Group Advises World Resource Solutions, Corp. in Its Sale to an Individual Buyer

DALLAS--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of World Resource Solutions, Corp. to an Individual Buyer. The acquisition closed January 6, 2026. Headquartered in Plain City, Ohio, World Resource Solutions, Corp. is a tooling and program management company founded in 2001 that serves the injection mold market and the automotive supply chain. The firm combines project management, procure...